Senores Pharmaceuticals Ltd.
Industry:
Pharmaceuticals & Drugs
Issue Details
Open Date
20 Dec 2024Close Date
24 Dec 2024Size (in Crs.)
333.706
Size (Shares)
-Listing On
BSE, NSE
Issue Terms
Price Range
-19Lot Size
38
Type
Book building
Face Value
10
Market Lot
1
Objective of the Issue
1.Investment in one of our Subsidiaries, Havix Group, Inc. d/b/a Aavis Pharmaceuticals (“Havix”), to fund capital expenditure requirements for setting up a manufacturing facility for the production of sterile injections in our Atlanta Facility.2.Re-payment/pre-payment, in full or in part, of certain borrowings availed by our Company.3.Investment in our Subsidiary, namely, Havix, for re- payment/pre-payment in full or in part, of certain borrowings availed by such Subsidiary.4.Funding the working capital requirements of our Company.5.Investment in our Subsidiaries, namely, Senores Pharmaceuticals Inc. (“SPI”) and Ratnatris Pharmaceutical Private Limited (“Ratnatris”) to fund their working capital requirements.6.Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes.
Description
We are a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Our strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing us as a preferred partner to certain customers. Through data analytics, research, market asses... Show More
Address
1101 To 1103, 11th Floor, South Tower , One 42 Opp. Jayantilal Park , Ambali Bopal Road
Ahmedabad
380054
Promoter Holding
Promoters:
Ashokkumar Vijaysinh Barot, Swapnil Jatinbhai Shah
Total Share Capital
22176079
Offered to Public
8534681
% Promoter's Holding (Pre-Issue)
66.67
% Promoter's Holding (Post-Issue)
45.76
Shares on offer
Total Share Offer
22176079
Of above offred to public
8534681
Post Issue shares
NA
Post Issue Promoters
45.76
Lead Managers to the Issue:
Ambit Pvt Ltd., Equirus Capital Pvt Ltd, Nuvama Wealth Management Ltd.
Registrar Details
Registrar Name:
MUFG Intime India Pvt Ltd.
Address
C 101, 247 Park , LBS Marg , Vikhroli (West) , Mumbai
400083
Phone No.
-
-
Website
-
Fax
-